NCT00688753 - RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

CarcinomaRenal CellNon Clear Cell Renal CarcinomaPapillary Cell Renal CarcinomaAdenocarcinoma

Interventions

DRUG

RAD001

Trial Locations (19)

9000

Novartis Investigative Site, Ghent

10098

Novartis Investigative Site, Berlin

13273

Novartis Investigative Site, Marseille

26100

Novartis Investigative Site, Cremona

27100

Novartis Investigative Site, Pavia

30625

Novartis Investigative Site, Hanover

33075

Novartis Investigative Site, Bordeaux

46009

Novartis Investigative Site, Valencia

48149

Novartis Investigative Site, Münster

52100

Novartis Investigative Site, Arezzo

69373

Novartis Investigative Site, Lyon

75015

Novartis Investigative Site, Paris

80132

Novartis Investigative Site, Napoli

94805

Novartis Investigative Site, Villejuif

BE-B-1200

Novartis Investigative Site, Brussels

05-400

Novartis Investigative Site, Otwock

08041

Novartis Investigative Site, Barcelona

08003

Novartis Investigative Site, Barcelona

08907

Novartis Investigative Site, Barcelona